Results 71 to 80 of about 98,800 (266)

Optimizing polytherapy management for Dravet syndrome in the United States: A National Expert Consensus

open access: yesEpilepsia Open, EarlyView.
ABSTRACT Objectives Dravet syndrome (DS) is a severe, drug‐resistant developmental and epileptic encephalopathy (DEE) that requires polytherapy for adequate seizure control. The need to combine multiple antiseizure medications (ASMs), together with variability in seizure types, safety considerations, and evolving patient needs, makes treatment ...
Elaine Wirrell, Joseph Sullivan
wiley   +1 more source

Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Mavacamten is the first and only cardiac myosin inhibitor approved in 5 continents for the treatment of adults with symptomatic New York Heart Association class II and III obstructive hypertrophic cardiomyopathy.
Anjali T. Owens   +6 more
doaj   +1 more source

Evaluation of Changes in Heart Rate Variability Associated with Puppy Growth Using Phase-Rectified Signal Averaging (PRSA) and Non-Gaussianity Index

open access: yesAnimals
Heart rate variability (HRV) reflects autonomic nervous system (ANS) activity through nonlinear mechanisms, including complex beat-to-beat fluctuations and chaos-like dynamics of healthy cardiac rhythms.
Rio Hayashi   +8 more
doaj   +1 more source

Longest survivor of pulmonary atresia with ventricular septal defect without surgical intervention

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1499-1507, April 2025.
Sang Zhou   +5 more
wiley   +1 more source

Heart failure in two male patients with late‐onset Fabry mutation (IVS4 + 919G > A)

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1508-1513, April 2025.
Xufei Yang   +3 more
wiley   +1 more source

Asymptomatic Cardiotoxicity After High‐Dose Anthracycline Treatment in Sarcoma Patients Assessed by Biomarkers and Echocardiography

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Treatment of sarcoma includes high‐dose anthracyclines, which can cause cardiotoxicity. This study assesses the correlation of cardiac biomarkers and echocardiographic parameters on asymptomatic cardiotoxicity in sarcoma patients treated with anthracyclines.
Elissa A. S. Polomski   +6 more
wiley   +1 more source

Percutaneous Thrombectomy Using AngioJet in Acute Pulmonary Embolism With Clot in Transit

open access: yesRespirology Case Reports
Percutaneous pulmonary thrombectomy using the AngioJet device is a feasible option for the management of acute pulmonary embolism with a clot in transit in selected high‐risk patients. Further large‐scale studies are needed to better establish the safety
Atif Saleem Siddiqui
doaj   +1 more source

Two causes of COVID‐19‐related myocardial injury‐associated cardiogenic shock: Myocarditis and microvascular thrombosis

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai   +4 more
wiley   +1 more source

Maternal and perinatal outcomes of pregnant women with echocardiographically high probability of pulmonary arterial hypertension

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective This study aimed to describe maternal and perinatal outcomes among pregnant women with echocardiographically high probability of pulmonary arterial hypertension (PAH) managed at a quaternary center and to compare outcomes between women with and without cardiac complications (CC).
Laura Belmont‐Rojo   +6 more
wiley   +1 more source

Pediatric syncope in specialty clinics: Clinical characteristics and lessons learned

open access: yesInternational Journal of Pediatrics & Adolescent Medicine
Background Syncope is a common symptom in pediatric clinics, with neurocardiogenic syncope being the most frequent etiology. The evaluation approach varies, as does the diagnostic yield. Objectives This study aims to evaluate the demographic and clinical
Amal Abu Libdeh   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy